SCOPUS 정보 검색 플랫폼

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 12, 2014, Pages 7595-7596

In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae

(3) Kohlhoff, Stephan A a Hub, Michael D b Hammerschlaga, Margaret R a

a SUNY DOWNSTATE MEDICAL CENTER (United States)

b AstraZeneca R and D Boston (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; AZD 0914; AZITHROMYCIN; DOXYCYCLINE; GYRASE INHIBITOR; LEVOFLOXACIN; UNCLASSIFIED DRUG; BARBITURIC ACID DERIVATIVE; DNA TOPOISOMERASE (ATP HYDROLYSING); SPIRO COMPOUND; ZOLIFLODACIN;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CLEARANCE; BACTERIUM ISOLATE; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; DRUG EFFICACY; HUMAN; IN VITRO STUDY; MINIMUM BACTERICIDAL CONCENTRATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; CHLAMYDIA PNEUMONIAE; DRUG EFFECTS; ENZYMOLOGY; GROWTH, DEVELOPMENT AND AGING; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BARBITURATES; CHLAMYDIA TRACHOMATIS; CHLAMYDOPHILA PNEUMONIAE; DNA GYRASE; DOXYCYCLINE; LEVOFLOXACIN; MICROBIAL SENSITIVITY TESTS; SPIRO COMPOUNDS; TOPOISOMERASE II INHIBITORS;

EID: 84912085949 PISSN: 00664804 EISSN: 10986596 Source Type: Journal
DOI: 10.1128/AAC.03920-14 Document Type: Article

Times cited : (21)

References (9)

1
- 1842842513
- U.S. Department of Health and Human Services, Atlanta, GA
- Centers for Disease Control and Prevention. 2012. Sexually transmitted disease surveillance 2011. U.S. Department of Health and Human Services, Atlanta, GA. http://www.cdc.gov/std/stats11/surv2011.pdf.
- (2012) Sexually Transmitted Disease Surveillance 2011
- Centers for Disease Control and Prevention¹

2
- 84896819016
- Chlamydia (Chlamydophila) pneumoniae
- Mandell GL, Bennett JE, Dolin R 7th ed Elsevier, Philadelphia, PA
- th ed, vol 1. Elsevier, Philadelphia, PA.
- (2010) Mandell, Douglas and Bennett's Principles and Practice Of Infectious Diseases , vol.1 , pp. 2467-2475
- Hammerschlag, M.R.¹ Kohlhoff, S.A.² Apfalter, P.M.³

3
- 79959897160
- Quinolones: Anti-infective therapy
- Mandell GL, Bennett JE, Dolin R 7th ed Elsevier, Philadelphia, PA
- th ed, vol 1. Elsevier, Philadelphia, PA.
- (2010) Mandell, Douglas and Bennett's Principles and Practice Of Infectious Diseases , vol.1 , pp. 487-490
- Hooper, D.C.¹ Strahilevitz, J.²

4
- 84906090956
- High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea
- Jacobsson S, Golparian D, Alm RA, Huband M, Mueller J, Jensen JS, Ohnishi M, Unemo M. 2014. High in vitro activity of the novel spiropyrimidinetrione AZD0914, a DNA gyrase inhibitor, against multidrug resistant Neisseria gonorrhoeae isolates suggests a new effective option for oral treatment of gonorrhea. Antimicrob. Agents. Chemother. 58:5585-5588. http://dx.doi.org/10.1128/AAC.03090-14.
- (2014) Antimicrob. Agents. Chemother. , vol.58 , pp. 5585-5588
- Jacobsson, S.¹ Golparian, D.² Alm, R.A.³ Huband, M.⁴ Mueller, J.⁵ Jensen, J.S.⁶ Ohnishi, M.⁷ Unemo, M.⁸

5
- 84912060588
- Benzisoxazoles: In vitro activity of new bacterial DNA gyrase/topoisomerase IV inhibitors against Grampositive, fastidious Gram-negative, atypical, and anaerobic bacterial isolates, poster F-1220. Abstr
- CO, 10 to 13 September 2013
- rd Annu. Intersci. Conf. Antimicrob. Agents Chemother., Denver, CO, 10 to 13 September 2013.
- (2013) 53rd Annu. Intersci. Conf. Antimicrob. Agents Chemother., Denver
- Huband, M.D.¹ Otterson, L.G.² Doig, P.C.³ Giacobbe, R.A.⁴ Patey, S.A.⁵ Gowravaram, M.⁶ Basarab, G.S.⁷ Mueller, J.P.⁸

6
- 0026623438
- Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae
- Roblin PM, Dumornay W, Hammerschlag MR. 1992. Use of HEp-2 cells for improved isolation and passage of Chlamydia pneumoniae. J. Clin. Microbiol. 30:1968-1971.
- (1992) J. Clin. Microbiol. , vol.30 , pp. 1968-1971
- Roblin, P.M.¹ Dumornay, W.² Hammerschlag, M.R.³

7
- 0029066694
- Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric commu-nity-acquired pneumonia: Comparative efficacy and safety of clarithromycin vs. Erythromycin ethylsuccinate
- Block SJ, Hedrick J, Hammerschlag MR, Cassell GH, Craft C. 1995. Mycoplasma pneumoniae and Chlamydia pneumoniae in pediatric commu-nity-acquired pneumonia: comparative efficacy and safety of clarithromycin vs. erythromycin ethylsuccinate. Pediatr. Infect. Dis. J. 14:471-477. http://dx.doi.org/10.1097/00006454-199506000-00002.
- (1995) Pediatr. Infect. Dis. J. , vol.14 , pp. 471-477
- Block, S.J.¹ Hedrick, J.² Hammerschlag, M.R.³ Cassell, G.H.⁴ Craft, C.⁵

8
- 84857339800
- Treatment of chlamydial infections
- Hammerschlag MR, Kohlhoff SA. 2012. Treatment of chlamydial infections. Expert Opin. Pharmacother. 13:542-552. http://dx.doi.org/10.1517 /14656566.2012.658776.
- (2012) Expert Opin. Pharmacother. , vol.13 , pp. 542-552
- Hammerschlag, M.R.¹ Kohlhoff, S.A.²

9
- 0031962016
- Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia
- Roblin PM, Hammerschlag MR. 1998. Microbiologic efficacy of azithromycin and susceptibilities to azithromycin of isolates of Chlamydia pneumoniae from adults and children with community-acquired pneumonia. Antimicrob. Agents Chemother. 42:194-196.
- (1998) Antimicrob. Agents Chemother. , vol.42 , pp. 194-196
- Roblin, P.M.¹ Hammerschlag, M.R.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.